{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:58:32Z","timestamp":1781657912447,"version":"3.54.5"},"reference-count":31,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Gynecology Obstetrics and Human Reproduction"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.jogoh.2017.11.002","type":"journal-article","created":{"date-parts":[[2017,11,6]],"date-time":"2017-11-06T16:37:20Z","timestamp":1509986240000},"page":"113-117","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Evaluation of effect of letrozole prior to misoprostol in comparison with misoprostol alone in success rate of induced abortion"],"prefix":"10.1016","volume":"47","author":[{"given":"T.","family":"Behroozi-Lak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Derakhshan-Aydenloo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Broomand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jogoh.2017.11.002_bib0160","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1363\/3217506","article-title":"Unwanted pregnancy and associated factors among Nigerian women","volume":"32","author":"Sedgh","year":"2006","journal-title":"Int Fam Plan Perspect"},{"key":"10.1016\/j.jogoh.2017.11.002_bib0165","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1016\/S0140-6736(07)61575-X","article-title":"Induced abortion: estimated rates and trends worldwide","volume":"370","author":"Sedgh","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.jogoh.2017.11.002_bib0170","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/S0968-8080(10)36537-2","article-title":"Unsafe abortion in 2008: global and regional levels and trends","volume":"18","author":"Shah","year":"2010","journal-title":"Reprod Health Matters"},{"key":"10.1016\/j.jogoh.2017.11.002_bib0175","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ijgo.2010.01.028","article-title":"Morbidity and mortality due to unsafe abortion in Pakistan","volume":"110","author":"Shaikh","year":"2010","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.jogoh.2017.11.002_bib0180","first-page":"871","article-title":"ACOG practice bulletin. Clinical management guidelines of obstetrician-gynecologists. Number 67, October 2005. Medical management of abortion","volume":"106","author":"ACOG","year":"2005","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jogoh.2017.11.002_bib0185","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0002-9378(97)70511-8","article-title":"Safety, efficacy, and acceptability of medical abortion in China, Cuba, and India: a comparative trial of mifepristone-misoprostol versus surgical abortion","volume":"176","author":"Winikoff","year":"1997","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jogoh.2017.11.002_bib0190","first-page":"505","article-title":"Randomized study of sulprostone versus misoprostol in the cervical preparation before elective abortion in nulliparous women","volume":"24","author":"Schaub","year":"1995","journal-title":"J Gynecol Obstet Biol Reprod"},{"key":"10.1016\/j.jogoh.2017.11.002_bib0195","doi-asserted-by":"crossref","first-page":"S178","DOI":"10.1016\/j.ijgo.2007.09.007","article-title":"Misoprostol for the termination of pregnancy with a live fetus at 13 to 26 weeks","volume":"99","author":"Ho","year":"2007","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.jogoh.2017.11.002_bib0200","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s00404-012-2508-y","article-title":"Sublingual versus vaginal misoprostol for second trimester termination: a randomized clinical trial","volume":"287","author":"Tanha","year":"2013","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.jogoh.2017.11.002_bib0205","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1093\/humrep\/den328","article-title":"Comparison of vaginal and sublingual misoprostol for second trimester abortion: Randomized controlled equivalence trial","volume":"24","author":"von Hertzen","year":"2009","journal-title":"Hum Reprod"},{"key":"10.1016\/j.jogoh.2017.11.002_bib0210","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1097\/01.AOG.0000289577.32274.a5","article-title":"Mifepristone in second-trimester medical abortion: a randomized controlled trial","volume":"110","author":"Kapp","year":"2007","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jogoh.2017.11.002_bib0215","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.contraception.2011.03.012","article-title":"A prospective double-blinded, randomized, placebo-controlled trial on the use of letrozole pretreatment with misoprostol for second-trimester medical abortion","volume":"84","author":"Lee","year":"2011","journal-title":"Contraception"},{"key":"10.1016\/j.jogoh.2017.11.002_bib0220","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/AOG.0b013e3182073fbf","article-title":"Misoprostol with or without letrozole pretreatment for termination of pregnancy: a randomized controlled trial","volume":"117","author":"Lee","year":"2011","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jogoh.2017.11.002_bib0225","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.fertnstert.2004.07.952","article-title":"Single-dose administration of an aromatase inhibitor for ovarian stimulation","volume":"83","author":"Mitwally","year":"2005","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jogoh.2017.11.002_bib0230","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.fertnstert.2005.05.078","article-title":"A new era in ovulation induction","volume":"85","author":"Holzer","year":"2006","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jogoh.2017.11.002_bib0235","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1056\/NEJM200101043440107","article-title":"Misoprostol and pregnancy","volume":"344","author":"Goldberg","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jogoh.2017.11.002_bib0240","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1471-0528.2009.02329.x","article-title":"The use of misoprostol in obstetrics and gynaecology","volume":"116","author":"Elati","year":"2009","journal-title":"BJOG"},{"key":"10.1016\/j.jogoh.2017.11.002_bib0245","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.12669\/pjms.296.3361","article-title":"Misoprostol abortion: ultrasonography versus Beta-hCG testing for verification of effectiveness","volume":"29","author":"Behnamfar","year":"2013","journal-title":"Pak J Med Sci"},{"key":"10.1016\/j.jogoh.2017.11.002_bib0250","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s00404-007-0374-9","article-title":"Randomized comparison of second trimester pregnancy termination utilizing saline moistened or dry misoprostol","volume":"276","author":"Yilmaz","year":"2007","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.jogoh.2017.11.002_bib0255","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1093\/humrep\/15.3.709","article-title":"A comparison of two regimens of intravaginal misoprostol for termination of second trimester pregnancy: a randomized comparative trial","volume":"15","author":"Wong","year":"2000","journal-title":"Hum Reprod"},{"key":"10.1016\/j.jogoh.2017.11.002_bib0260","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0010-7824(98)00099-7","article-title":"Vaginal misoprostol compared with vaginal gemeprost in termination of second trimester pregnancy. A randomized trial","volume":"58","author":"Wong","year":"1998","journal-title":"Contraception"},{"key":"10.1016\/j.jogoh.2017.11.002_bib0265","doi-asserted-by":"crossref","first-page":"3062","DOI":"10.1093\/humrep\/dei196","article-title":"A prospective randomized comparison of sublingual and oral misoprostol when combined with mifepristone for medical abortion at 12-20 weeks gestation","volume":"20","author":"Tang","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.jogoh.2017.11.002_bib0270","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s00404-011-1949-z","article-title":"A randomized comparative study on vaginal administration of acetic acid-moistened versus dry misoprostol for mid-trimester pregnancy termination","volume":"285","author":"Bhattacharjee","year":"2012","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.jogoh.2017.11.002_bib0275","first-page":"283","article-title":"A comparative study on sublingual versus oral and vaginal administration of misoprostol for late first and early second trimester abortion","volume":"108","author":"Ganguly","year":"2010","journal-title":"J Indian Med Assoc"},{"key":"10.1016\/j.jogoh.2017.11.002_bib0280","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.contraception.2012.05.009","article-title":"A pilot study on the use of a 7-day course of letrozole followed by misoprostol for the termination of early pregnancy up to 63 days","volume":"86","author":"Yeung","year":"2012","journal-title":"Contraception"},{"key":"10.1016\/j.jogoh.2017.11.002_bib0285","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.ejogrb.2013.09.017","article-title":"A pilot study on the combined use of letrozole, mifepristone and misoprostol in termination of first trimester pregnancy up to 9 weeks\u2019 gestation","volume":"171","author":"Chai","year":"2013","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.jogoh.2017.11.002_bib0290","doi-asserted-by":"crossref","first-page":"S184","DOI":"10.1067\/mob.2002.122592","article-title":"Nausea and vomiting of pregnancy: an obstetric syndrome","volume":"186","author":"Goodwin","year":"2002","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jogoh.2017.11.002_bib0295","doi-asserted-by":"crossref","first-page":"S172","DOI":"10.1016\/j.ijgo.2007.09.006","article-title":"Misoprostol for the termination of pregnancy up to 12 completed weeks of pregnancy","volume":"99","author":"Fa\u00fandes","year":"2007","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.jogoh.2017.11.002_bib0300","first-page":"41","article-title":"Comparison of sublingual and vaginal misoprostol for second-trimester pregnancy terminations","volume":"8","author":"Milani","year":"2014","journal-title":"J Family Reprod Health"},{"key":"10.1016\/j.jogoh.2017.11.002_bib0305","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1111\/j.1471-0528.2010.02636.x","article-title":"Misoprostol dose and route after mifepristone for early medical abortion: a randomised controlled noninferiority trial","volume":"117","author":"von Hertzen","year":"2010","journal-title":"BJOG"},{"key":"10.1016\/j.jogoh.2017.11.002_bib0310","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.contraception.2010.05.014","article-title":"A pilot study on the use of letrozole with either misoprostol or mifepristone for termination of pregnancy up to 63 days","volume":"83","author":"Lee","year":"2011","journal-title":"Contraception"}],"container-title":["Journal of Gynecology Obstetrics and Human Reproduction"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S246878471730226X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S246878471730226X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,26]],"date-time":"2018-08-26T03:26:59Z","timestamp":1535254019000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S246878471730226X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["S246878471730226X"],"URL":"https:\/\/doi.org\/10.1016\/j.jogoh.2017.11.002","relation":{},"ISSN":["2468-7847"],"issn-type":[{"value":"2468-7847","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of effect of letrozole prior to misoprostol in comparison with misoprostol alone in success rate of induced abortion","name":"articletitle","label":"Article Title"},{"value":"Journal of Gynecology Obstetrics and Human Reproduction","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jogoh.2017.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}